[HTML][HTML] Global pandemics interconnected—obesity, impaired metabolic health and COVID-19

N Stefan, AL Birkenfeld, MB Schulze - Nature Reviews Endocrinology, 2021 - nature.com
Obesity and impaired metabolic health are established risk factors for the non-
communicable diseases (NCDs) type 2 diabetes mellitus, cardiovascular disease …

Association of obesity with COVID-19 severity and mortality: an updated systemic review, meta-analysis, and meta-regression

R Singh, SS Rathore, H Khan, S Karale… - Frontiers in …, 2022 - frontiersin.org
Background Obesity affects the course of critical illnesses. We aimed to estimate the
association of obesity with the severity and mortality in coronavirus disease 2019 (COVID …

Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on coronary pathophysiology & microcirculation, ESC working group on …

E Cenko, L Badimon, R Bugiardini… - Cardiovascular …, 2021 - academic.oup.com
The cardiovascular system is significantly affected in coronavirus disease-19 (COVID-19).
Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or …

Obesity as a risk factor for severe COVID-19 and complications: a review

F Demeulemeester, K de Punder, M van Heijningen… - Cells, 2021 - mdpi.com
Emerging data suggest that obesity is a major risk factor for the progression of major
complications such as acute respiratory distress syndrome (ARDS), cytokine storm and …

Body mass index, practice of physical activity and lifestyle of students during COVID-19 lockdown

SM Jalal, MRM Beth, HJM Al-Hassan… - Journal of …, 2021 - Taylor & Francis
Purpose Several factors influence the student's physical activity and lifestyle. The
coronavirus disease (COVID‐19) lockdown has restricted student's activity and altered their …

A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity

J Xu, W **ao, X Liang, L Shi, P Zhang, Y Wang… - BMC public health, 2021 - Springer
Background Cardiovascular disease (CVD), one of the most common comorbidities of
coronavirus disease 2019 (COVID-19), has been suspected to be associated with adverse …

Dyslipidemia increases the risk of severe COVID-19: a systematic review, meta-analysis, and meta-regression

IS Atmosudigdo, MA Lim, B Radi… - Clinical Medicine …, 2021 - journals.sagepub.com
Objective: This systematic review and meta-analysis aimed to evaluate whether
dyslipidemia affects the mortality and severity of COVID-19, we also aimed to evaluate …

[HTML][HTML] Type 2 diabetes mellitus and COVID-19: a narrative review

C Rey-Reñones, S Martinez-Torres, FM Martín-Luján… - Biomedicines, 2022 - mdpi.com
Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The incidence and
prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values …

COVID‐19 lockdown consequences on body mass index and perceived fragility related to physical activity: A worldwide cohort study

C Urzeala, M Duclos, U Chris Ugbolue… - Health …, 2022 - Wiley Online Library
Background This paper is a follow‐up study continuing the COVISTRESS network previous
research regarding health‐related determinants. Objective The aim was to identify the main …